Longboard Pharmaceuticals, Inc entered into a Non-Voting Common Stock Purchase Agreement and issued 2,850,000 shares of its non-voting common stock to the Investor at a purchase price of $21 per share, for aggregate gross proceeds of $59,850,000 on March 26, 2024. The transaction included participation from returning investor, Farallon Capital Management, L.L.C.